With reference to her reply to question 142 on 23 March 2022, what total number of African horse sickness vaccines (a) were produced between January 2022 and February 2023 as promised by her and (b) are currently in stock;
(2) whether the specified stock is sufficient for the next vaccination cycle; if not, why not; if so, what are the relevant details;
(3) whether Onderstepoort Biological Products is prepared to supply the necessary attenuated strains and serotypes to a private production entity to further develop alternative production as quickly as possible; if not, (a) why not and (b) how does she intend to solve the shortage of vaccines challenges; if so, by what date does she envisage this will happen?